1. Endo, Inc. rescheduled Q4 2024 financial results to March 13, 2025. 2. Conference call scheduled for March 13 at 8:00 a.m. ET. 3. Investors can access webcast on Endo's Investor Relations website. 4. The delay may impact investor sentiment and market reactions. 5. Replay of the conference call will be available post-event.
While a financial results announcement is important, rescheduling typically does not signal significant changes in underlying performance. Historical data shows similar delays often lead to temporary market reactions, but do not change the long-term outlook.
The announcement of financial results can significantly influence stock price in the short term; however, the neutral tone limits broader implications.
The short-term impact revolves around investor sentiment leading up to the results, but the long-term trajectory will depend on the actual results themselves. Past instances show that initial market reactions to such announcements stabilize shortly after the results are released.
MALVERN, Pa., March 10, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it has rescheduled the release of its fourth quarter and full year 2024 financial results to March 13, 2025, prior to market open. The Company will host a conference call on the same day at 8:00 a.m. ET.
The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.